TY  - JOUR

T1  - Trabectedin for the treatment of relapsed ovarian cancer

JO  - Health Technology Assessment

PY  - 2011/05/01

AU  - Papaioannou D

AU  - Rafia R

AU  - Stevenson MD

AU  - Stevens JW

AU  - Evans P

ED  - 

DO  - DOI: 10.3310/hta15suppl1-08

PB  - National Institute for Health Research

VL  - 15

IS  - Suppl 1

SP  - 69

EP  - 75

Y2  - 2024/10/18

ER  -